Drug Pipeline

Paxalisib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT03970447 A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Glioblastoma Recruiting
Phase 2
NCT07447076 Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid… Recurrent Atypical Teratoid/Rhabdoid Tumor Not Yet Recruiting
Phase 1/2
NCT06208657 Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer Childhood Cancer Recruiting
NCT07391215 5G-PEARL: Paxalisib in Malignant Brain Tumours Malignant Primary Gliomas Recruiting
Phase 1
NCT04192981 GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain… Brain Metastases Active, Not Recruiting
Sponsors Running Paxalisib Trials
Global Coalition for Adaptive Research (1) Memorial Sloan Kettering Cancer Center (1) Australian & New Zealand Children's Haematology/Oncology Group (1) Institute of Cancer Research, United Kingdom (1) Sabine Mueller, MD, PhD (1)
Disease Areas
Glioblastoma (2) Glioma (1)
Get alerts when Paxalisib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free